Mark Rogge
Impact in
- Pharmaceutical Science top 0.5%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
- Pharmacology 15
- Antibiotics Pharmacokinetics and Efficacy 14
- Pharmacogenetics and Drug Metabolism 5
-
- Pharmaceutical studies and practices 7
- Pharmacological Effects and Toxicity Studies 5
- Co-authors
- William N. Charman (3 shared papers)Frank J. Dutko (2 shared papers)Wei Yin (2 shared papers)Terry D. Wilson (1 shared paper)Susan A. Charman (1 shared paper)Colin W. Pouton (1 shared paper)Bruce M. Berger (2 shared papers)Andrew Chow (5 shared papers)
- Journals
- The Journal of Clinical Pharmacology (11 papers)Antimicrobial Agents and Chemotherapy (9 papers)Clinical Pharmacology & Therapeutics (6 papers)Biopharmaceutics & Drug Disposition (3 papers)CPT Pharmacometrics & Systems Pharmacology (2 papers)
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
Mark Rogge
60 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 122
- Pharmaceutical Science 404
- Molecular Medicine 146
- Pharmacology 414
- Pharmacology 126
- Analytical Chemistry 116
Countries citing papers authored by Mark Rogge
This map shows the geographic impact of Mark Rogge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Rogge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Rogge more than expected).
Fields of papers citing papers by Mark Rogge
This network shows the impact of papers produced by Mark Rogge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Rogge. The network helps show where Mark Rogge may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Rogge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 319 | |
| 2 | 1997 | 189 | |
| 3 | 1992 | 124 | |
| 4 | 1993 | 120 | |
| 5 | 2019 | 113 | |
| 6 | 2011 | 91 | |
| 7 | 1997 | 75 | |
| 8 | 2015 | 72 | |
| 9 | 2006 | 66 | |
| 10 | 1989 | 52 | |
| 11 | 2007 | 51 | |
| 12 | 1997 | 50 | |
| 13 | 1993 | 46 | |
| 14 | 1984 | 45 | |
| 15 | 1997 | 42 | |
| 16 | Immunomodulation by LFA3TIP, an LFA-3/IgG1 fusion protein: cell line dependent glycosylation effects on pharmacokinetics and pharmacodynamic markers. | 1995 | 41 |
| 17 | 2014 | 40 | |
| 18 | 1988 | 40 | |
| 19 | 1994 | 38 | |
| 20 | 1984 | 29 |
About Mark Rogge
Mark Rogge is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health, Immunology, Molecular Biology and Oncology, having authored 62 papers that have together received 2.1k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (14 papers), Pharmaceutical studies and practices (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Pharmacogenetics and Drug Metabolism (5 papers), T-cell and B-cell Immunology (5 papers), Pharmacological Effects and Toxicity Studies (5 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Systemic Lupus Erythematosus Research (4 papers). The work is most often cited by research in Pharmaceutical Science (404 citations), Molecular Medicine (146 citations), Pharmacology (414 citations), Pharmacology (126 citations) and Analytical Chemistry (116 citations). Mark Rogge has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include William N. Charman, Frank J. Dutko, Wei Yin, Terry D. Wilson, Susan A. Charman, Colin W. Pouton, Bruce M. Berger, Andrew Chow, R. Rex Williams and Shuchean Chien. Their work appears in journals such as The Journal of Clinical Pharmacology, Antimicrobial Agents and Chemotherapy, Clinical Pharmacology & Therapeutics, Biopharmaceutics & Drug Disposition and CPT Pharmacometrics & Systems Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.